4basebio PLC (88Q.DE) XETRA

6.70

+0.2(+3.08%)

Updated at December 23 05:35PM

Currency In EUR

Valuation

Market Cap156.32M
Enterprise Value136.94M
P/E Ratio-6.61
PEG Ratio1.27
Price/Sales Ratio53.53
Price/Book Ratio5.02
Enterprise/Revenue47.53
Enterprise/EBITDA-5.57

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-8.1
Operating Margin-10.73

Management Effectiveness

Return On Assets-0.39
Return On Equity-0.64

Income Statement

Revenue933,000
Revenue/Share0.11
Gross Profit630,000
EBITDA-10.97M
Net Income-12.33M
Diluted EPS-0.94

Balance Sheet

Total Cash26.11M
Total Cash/Share1.69
Total Debt15.44M
Total Debt/Equity0.81
Current Ratio11.36
Book Value Per Share1.23

Price History

52-Week Change-52.82
52-Week High14.6
52-Week Low6.4
Moving Average 50 Days8.2
Moving Average 200 Days10.66

Statistics

Average Volume41
Shares Outstanding15.48M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A